Fengling Zhang

864 total citations
30 papers, 723 citations indexed

About

Fengling Zhang is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Biomedical Engineering. According to data from OpenAlex, Fengling Zhang has authored 30 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 8 papers in Epidemiology and 8 papers in Biomedical Engineering. Recurrent topics in Fengling Zhang's work include Photodynamic Therapy Research Studies (8 papers), Nanoplatforms for cancer theranostics (7 papers) and Porphyrin and Phthalocyanine Chemistry (5 papers). Fengling Zhang is often cited by papers focused on Photodynamic Therapy Research Studies (8 papers), Nanoplatforms for cancer theranostics (7 papers) and Porphyrin and Phthalocyanine Chemistry (5 papers). Fengling Zhang collaborates with scholars based in China, Australia and India. Fengling Zhang's co-authors include Jingwei Shao, Jia Li, Jinping Xue, Qi Huang, Xiang Fu, Ke Zheng, Jianyong Liu, Jun Li, Mingdong Huang and Xiaoxia Zhang and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and Emerging infectious diseases.

In The Last Decade

Fengling Zhang

29 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengling Zhang China 14 233 226 204 180 98 30 723
Andreas Kubin Austria 13 342 1.5× 463 2.0× 213 1.0× 124 0.7× 47 0.5× 22 877
Pankaj Chaturvedi India 13 139 0.6× 141 0.6× 161 0.8× 74 0.4× 112 1.1× 52 719
Ge Hong China 13 144 0.6× 135 0.6× 222 1.1× 108 0.6× 35 0.4× 35 659
Dejene Tolossa Debela Ethiopia 4 199 0.9× 93 0.4× 355 1.7× 97 0.5× 198 2.0× 6 963
Deep Kwatra United States 16 184 0.8× 141 0.6× 238 1.2× 73 0.4× 195 2.0× 28 810
Qikun Jiang China 17 455 2.0× 176 0.8× 308 1.5× 175 1.0× 108 1.1× 52 945
J. Lambea Spain 11 184 0.8× 203 0.9× 333 1.6× 97 0.5× 285 2.9× 26 1.0k
Qunyou Tan China 20 140 0.6× 134 0.6× 438 2.1× 68 0.4× 122 1.2× 48 1.0k
Vineela Parvathaneni United States 19 248 1.1× 352 1.6× 476 2.3× 43 0.2× 164 1.7× 25 1.3k
Zongning Yin China 20 177 0.8× 74 0.3× 390 1.9× 143 0.8× 91 0.9× 59 1.2k

Countries citing papers authored by Fengling Zhang

Since Specialization
Citations

This map shows the geographic impact of Fengling Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengling Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengling Zhang more than expected).

Fields of papers citing papers by Fengling Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengling Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengling Zhang. The network helps show where Fengling Zhang may publish in the future.

Co-authorship network of co-authors of Fengling Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Fengling Zhang. A scholar is included among the top collaborators of Fengling Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengling Zhang. Fengling Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Xiaoqian, et al.. (2024). Sanmiao wan alleviates inflammation and exhibits hypouricemic effect in an acute gouty arthritis rat model. Journal of Ethnopharmacology. 324. 117764–117764. 6 indexed citations
3.
Zhang, Fengling, et al.. (2023). Inhibitory Effects and Related Molecular Mechanisms of Huanglian-Ganjiang Combination Against H1N1 Influenza Virus. Revista Brasileira de Farmacognosia. 33(3). 514–522. 1 indexed citations
4.
Zhong, Guohui, Jie Guo, Di Su, et al.. (2022). Novel AP2238-clorgiline hybrids as multi-target agents for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation. Bioorganic Chemistry. 130. 106224–106224. 13 indexed citations
5.
Zhang, Fengling, et al.. (2021). Pharmacokinetics and Pharmacodynamics of Huanglian-Houpo Decoction Based on Berberine Hydrochloride and Magnolol Against H1N1 Influenza Virus. European Journal of Drug Metabolism and Pharmacokinetics. 47(1). 57–67. 11 indexed citations
6.
Zhong, Weimin, et al.. (2021). Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy via Multi-Omics Analysis. Frontiers in Molecular Biosciences. 8. 684050–684050. 14 indexed citations
7.
Zhang, Wanwan, Fengling Zhang, Ming Yang, et al.. (2021). Prognostic Role and Diagnostic Power of Seven Indicators in COVID-19 Patients. Frontiers in Medicine. 8. 733274–733274. 7 indexed citations
8.
Zhong, Weimin, et al.. (2021). Identification of an apoptosis-related prognostic gene signature and molecular subtypes of clear cell renal cell carcinoma (ccRCC). Journal of Cancer. 12(11). 3265–3276. 10 indexed citations
9.
Zhong, Weimin, et al.. (2021). Classification of Clear Cell Renal Cell Carcinoma based on Tumor Suppressor Genomic Profiling. Journal of Cancer. 12(8). 2359–2370. 2 indexed citations
10.
Xiao, Shune, Fengling Zhang, Zhiyuan Liu, et al.. (2020). Synergistic effect of nanofat and mouse nerve-growth factor for promotion of sensory recovery in anterolateral thigh free flaps. Stem Cells Translational Medicine. 10(2). 181–189. 10 indexed citations
11.
12.
Chen, Juanjuan, Dongyao Li, Fengling Zhang, et al.. (2019). Epidermal Growth Factor Receptor-Targeted Delivery of a Singlet-Oxygen Sensitizer with Thermal Controlled Release for Efficient Anticancer Therapy. Molecular Pharmaceutics. 16(8). 3703–3710. 18 indexed citations
13.
Li, Jin, et al.. (2018). Evaluation of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for identifying Burkholderia pseudomallei and Burkholderia thailandensis isolates. European Journal of Clinical Microbiology & Infectious Diseases. 38(1). 191–196. 4 indexed citations
14.
Chang, Kai‐Ming, Jie Luo, Huan Xu, et al.. (2017). Human Infection with Burkholderia thailandensis, China, 2013. Emerging infectious diseases. 23(8). 1416–1418. 25 indexed citations
15.
Li, Rui, Ke Zheng, Ping Hu, et al.. (2014). A Novel Tumor Targeting Drug Carrier for Optical Imaging and Therapy. Theranostics. 4(6). 642–659. 59 indexed citations
16.
Zhou, Xiaoqin, Qi Huang, Jun Li, et al.. (2014). Synthesis and in vitro Anticancer Activity of Zinc(II) Phthalocyanines Conjugated with Coumarin Derivatives for Dual Photodynamic and Chemotherapy. ChemMedChem. 10(2). 304–311. 32 indexed citations
17.
Zhang, Fengling, Qi Huang, Jianyong Liu, Mingdong Huang, & Jinping Xue. (2014). Molecular‐Target‐Based Anticancer Photosensitizer: Synthesis and in vitro Photodynamic Activity of Erlotinib–Zinc(II) Phthalocyanine Conjugates. ChemMedChem. 10(2). 312–320. 31 indexed citations
18.
Zhang, Fengling, Qi Huang, Ke Zheng, et al.. (2013). A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(ii) phthalocyanine and small molecule target-based anticancer drug erlotinib. Chemical Communications. 49(83). 9570–9570. 70 indexed citations
19.
Zhang, Fengling, Yan Li, Sufang Huang, & Xiangjun Bai. (2013). Correlations between quality indexes of chest compression. World Journal of Emergency Medicine. 4(1). 54–54. 9 indexed citations
20.
Zhang, Fengling, et al.. (2011). Compilation of 222 drugs’ plasma protein binding data and guidance for study designs. Drug Discovery Today. 17(9-10). 475–485. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Kubin Breakdown of academic impact, for papers by Pankaj Chaturvedi Breakdown of academic impact, for papers by Ge Hong Breakdown of academic impact, for papers by Dejene Tolossa Debela Breakdown of academic impact, for papers by Deep Kwatra Breakdown of academic impact, for papers by Qikun Jiang Breakdown of academic impact, for papers by J. Lambea Breakdown of academic impact, for papers by Qunyou Tan Breakdown of academic impact, for papers by Vineela Parvathaneni Breakdown of academic impact, for papers by Zongning Yin
Rankless by CCL
2026